All lobbying filings
FORBES-TATE
FORBES-TATE filed a Q3 report for GRAIL, INC. on October 18, 2026, reporting $50,000 in lobbying income.
Lobbying for GRAIL, INC. · Biotechnology Company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 18, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
2
Lobbying activity
2
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.